Abstract
Characterization of enzyme kinetics in an experiment is dependent on measurement of a change in concentration of either the substrate (loss of parent) or the product (formation of metabolite). Modern analytical techniques such as ultrahigh pressure liquid chromatography and high-resolution mass spectrometry have allowed accurate characterization of minute changes in concentration. Therefore, complex kinetic data such as a sigmoidal phase at low substrate concentrations or terminal half-life in a PK curve can be evaluated by stretching the limits of analytical quantification. This chapter presents some elementary do’s and don’ts and provides insight into some of the underlying principles for utilizing the best possible analytical techniques when investigating enzyme kinetics. The objective of this case study is to answer the following questions:
-
(a)
Why is it necessary to determine lower and upper limits of quantification (LLOQ and ULOQ, respectively) of a bioanalytical assay specifically for enzyme kinetic assays? How do you utilize LLOQ and ULOQ to correctly interpret your kinetic data?
-
(b)
Why should one use a linear fit and not a quadratic fit for standard curves?
-
(c)
Is quantification of an analyte possible without a reference standard? Can one assume equal signal intensities regardless of analytical technique (MS, UV)?
-
(d)
In the absence of reference standards, can you still determine kinetic constants?
-
(e)
With the need to keep substrate depletion at less than 20 % for linearity assumptions, does bioanalytical variability matter?
-
(f)
What buffer do you use for your enzyme systems? How do you choose your buffer? Does choice of bioanalytical methods (LC, MS) dictate your choice of buffer?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Remmel RP, Nagar S, Argikar U (2008) Conjugative metabolism of drugs in drug metabolism in drug design and development. Wiley, New York, NY
Mosher CM, Rettie AE (2009) Transformation enzymes: oxidative; non-P450. In: Pearson PG, Wienkers LC (eds) Handbook of drug metabolism, 2nd edn. Informa Healthcare, New York, pp 109–135
Gunduz M, Argikar UA, Baeschlin D, Ferreira S, Hosagrahara V, Harriman S (2010) Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo and mechanistic studies. Drug Metab Dispos 38:361–367
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Argikar, U.A., Nagar, S. (2014). Case Study 2. Practical Analytical Considerations for Conducting In Vitro Enzyme Kinetic Studies. In: Nagar, S., Argikar, U., Tweedie, D. (eds) Enzyme Kinetics in Drug Metabolism. Methods in Molecular Biology, vol 1113. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-758-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-62703-758-7_19
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-757-0
Online ISBN: 978-1-62703-758-7
eBook Packages: Springer Protocols